MedPath

Promoting Cervical Cancer Screening Through the Advocacy of Screened Women

Phase 2
Completed
Conditions
Cervical Cancer Prevention
Interventions
Behavioral: WOMEN FIGHTING TO STOP CERVICAL CANCER
Registration Number
NCT04960748
Lead Sponsor
RAND
Brief Summary

This study pilots a 7-session group intervention among 40 screened women, 20 of whom will be randomly assigned to take part in the intervention, and 20 to the wait-list control. Assessments will be administered at baseline and month 6 to index participants as well as up to three unscreened female social network members of each index participant (up to 120 total). The primary outcome is CC screening among participating social network members.

Detailed Description

Cervical cancer (CC) is the most common cancer and accounts for \~25% of all cancer related deaths among women in Uganda, which has one of the highest incidence rates in the world. Adding to the burden is the general lack of knowledge about, and social stigma towards CC and its screening in Uganda, where lifetime CC screening is estimated to be as low as 5%. There is a dire need to increase CC screening in Uganda to ensure timely and lifesaving treatment, as well as the need to enhance the capacity to conduct behavioral and health services research related to CC and other stigmatizing conditions among local researchers and service providers. Accordingly, the proposed intervention pilot study seeks to (1) empower women who have been screened for CC, to advocate for CC screening and early treatment among women in their social networks, and (2) engage and train local public health researchers and programmers. The proposed intervention draws on theories of social diffusion, cognitive consistency, and social influence, and the investigator's recently developed and tested group intervention that mobilized people living with HIV in Uganda to successfully act as change agents for HIV prevention within their social networks. The intervention actively targets internalized stigma, disclosure decision making, healthy living, and advocacy communication skills. This study will pilot the intervention among 40 screened women, 20 of whom will be randomly assigned to take part in the intervention, and 20 to the wait-list control. Assessments will be administered at baseline and month 6 to index participants as well as up to three unscreened female social network members of each index participant (up to 120 total). The primary outcome is CC screening among participating social network members. The primary aims of the study are to assess the feasibility, acceptability and preliminary efficacy of the group intervention to promote CC screening and treatment; identify characteristics associated with successful advocacy; and increase local capacity for conducting public health research on CC control and use of social network-based intervention and measurement methods.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
143
Inclusion Criteria
  • age 18 years or older
  • has been previously screened for cervical cancer
  • has told at least one woman in her social network about her cervical cancer screening experience
Exclusion Criteria
  • unstable medical status (e.g., advance disease stage that calls into question her ability to complete the 6-month study)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
interventionWOMEN FIGHTING TO STOP CERVICAL CANCER7-sesson group intervention that uses dyadic instruction, role playing and group sharing and discussion to reduce internalized stigma, improve disclosure decision making and healthy living, and teach advocacy skills
Primary Outcome Measures
NameTimeMethod
Proportion of social network members who report cervical cancer screeningpast 6 months

cervical cancer screening among women in social network

Secondary Outcome Measures
NameTimeMethod
Proportion of index participants who self-report engagement in cervical cancer (CC) prevention advocacypast 6 months

discussing cervical cancer and encouraging CC screening with women in social network

Trial Locations

Locations (1)

Buyinja HCIV

🇺🇬

Namayingo, Uganda

© Copyright 2025. All Rights Reserved by MedPath